Health AI Central
Share:
Peer-Reviewed Publication
Dan Med J2025;72(8)July 8, 2025Journal Article

Opioid and benzodiazepine use among adolescents and young adults in Denmark.

Anne-Sofie Hartvig Klærke1, Kasper Iversen1,2, Michael Lodberg Olsen1, Sidsel Lauge West1, Natascha Nydal1, Lars Gadegaard Hansen1, Tina Leth1, Caroline Adolphsen1,3, Marianne Abildgaard1, Carl Martin Söderström1, Mads Bang-Nielsen1, Anders Bang-Nielsen1,4, Jakob Hartvig Thomsen1,5
1Antidote Danmark.
2Department of Medicine, Copenhagen University Hospital - Herlev and Gentofte Hospital.
3Department of Law, School of Business and Social Sciences, Aarhus University.
4Department of Surgery, Copenhagen University Hospital - North Zealand Hospital.
5Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Denmark.
PubMed DOI

Abstract

INTRODUCTION: We aimed to investigate the prevalence of opioid and benzodiazepine use among Danish youths aged 13-26 years, and to document their knowledge of opioids, benzodiazepines and overdose prevention. METHODS: An anonymous questionnaire was distributed via email and posters at youth educational institutions, and via social media. From September 2023 to April 2024, a total of 1,222 respons…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.